Calif. High Court To Review ‘Pay-for-Delay’ Rx Drug Deals

California is poised to become the first state to examine the legality of drugmakers paying competitors to delay production of low-cost generic versions of prescription drugs. Last month, the California Supreme Court agreed to review a 10-year-old class-action lawsuit involving Bayer, which paid Barr Pharmaceuticals to delay introduction of a generic version of the antibiotic Cipro.

• "State Court To Examine 'Pay-for-Delay' Deals by Drugmakers" (Yeung, California Watch, 3/2).